THEON International Wins €70M Orders, Forms Safran JV, Enters Counter-Drone Market

THEON International Plc announced a new order intake of approximately €70 million on June 22, 2026, bringing its year-to-date total to €223 million. The bulk of the new orders came from Rheinmetall for Germany's Bundeswehr Future Soldier program, known as Infanterist der Zukunft (IdZ) — a major effort to digitize the modern infantryman.
The announcement came alongside two other major moves: a joint venture with French defense giant Safran, with THEON holding a 51% stake, and a €300 million deal to acquire HGH Systèmes Infrarouges. Together, the three developments mark a sharp shift for THEON — from a night vision hardware maker to a broad defense technology platform, according to Financial Post.
The €70 million order is a key piece of Germany's IdZ program. The program aims to give infantry soldiers integrated digital vision — combining night vision and thermal imaging with real-time data overlays. THEON supplies this through its A.R.M.E.D. system, short for Augmented Reality Modular Ecosystem of Devices. The first A.R.M.E.D. orders for the IdZ program came in January 2025, according to Fort McMurray Today.
Q2 2026 order intake reached €153 million, plus €27 million in unexercised options. THEON's Deputy CEO Philippe Mennicken said the orders reflect "strong trust placed in THEON's technological expertise and execution capabilities." The company expects more options to be exercised later in the year and maintains its guidance for an organic book-to-bill ratio above 1.0x for full-year 2026.
On June 15, 2026, THEON signed an MoU with Safran Electronics & Defense to create a joint venture focused on UAV optronics — the sensors and cameras used on drones. THEON controls 51% of the venture; Safran holds 49%. Alexandre Ziegler of Safran called it "a concrete step in strengthening Europe's technological sovereignty in a critical defense domain," according to Recorder.
THEON CEO Christian Hadjiminas called it "a milestone move for THEON, bringing together our strengths with those of a global leader." The JV is part of a wider push to build a European-controlled supply chain. Crucially, the combined assets are ITAR-free — meaning they are not subject to U.S. export rules — making them attractive to allied nations that want to avoid American oversight.
Just two days after the Safran announcement, THEON entered exclusivity with Carlyle Group to buy HGH Systèmes Infrarouges for €300 million. HGH makes SPYNEL panoramic thermal sensors — considered a gold standard for passively detecting drones without emitting a radar signal. The deal marks THEON's direct entry into the fast-growing counter-drone, or C-UAS, market, according to County Market.
The acquisition will be funded by a BNP Paribas bridge loan. This will push THEON's net debt to roughly 3.0x EBITDA — a big jump from its previous net-cash position. The company says the deal will be EBITDA-margin accretive immediately and mid-single-digit EPS accretive by 2027. Carlyle had owned HGH for eight years, growing it from a niche industrial firm into a high-growth defense company.
THEON listed on Euronext Amsterdam in February 2024. Since then, it has moved fast. It acquired German firm Kappa, French drone gimbal maker Merio, and now HGH. The company's 2026 revenue guidance stands at €570–590 million. Its medium-term goal is €1 billion in annual revenue by 2030 — a target it now believes it can hit earlier than planned, according to Financial Post.
Some investors are cautious. Going from net-cash to 3.0x leverage in under a week raises questions about integration risk and interest rate exposure. Others are more optimistic — analysts at Simply Wall St suggested a potential 20% share price upside as the market prices in the new platform strategy. The speed of THEON's transformation makes it one of the most closely watched defense names in Europe right now.
Publishers
4
Articles
4
Reach
4